In a presentation at the Australia and New Zealand Biologics Festival, AdAlta chief executive Tim Oldham outlined the promise of these therapies and the structural challenges that affect their availability in Australia and Southeast Asia.
Australian biotech leader highlights the CAR-T access challenge for local Industry
February 21, 2026 Latest NewsAustralian Biotech
Latest Video
New Stories
-
The 'Dispatched' Week in Review' Podcast - 4 September
September 4, 2026 - - Podcast -
A three-pronged expansion of Commonwealth reach in therapeutic-goods regulation
September 4, 2026 - - Latest News -
If the government gives itself more power, don't be surprised when they use it
September 4, 2026 - - Latest News -
Medicines Australia calls for doubling of PBS medicines investment
September 4, 2026 - - Latest News -
Gilead returns to Medicines Australia as industry prepares to make the case for innovation
September 3, 2026 - - Latest News -
Combined monitoring of key indicators as the future of diabetes care
September 3, 2026 - - Latest News -
The live lesson from the UK on who holds the levers and how they use them
September 3, 2026 - - Latest News
